Human dermal MSCs expressing ATP-Binding Cassette member B5 (ABCB5) have shown therapeutic efficacy in clinical trials in chronic skin wounds or recessive dystrophic epidermolysis bullosa. This evidence concerns the gene ABCB5 and recessive dystrophic epidermolysis bullosa.